HOOKIPA Pharma Inc.
Other OTCTotal Valuation
HOOKIPA Pharma Inc. carries a market capitalization of 14.40M, placing it among publicly traded companies globally. Its enterprise value stands at -17.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14.40M |
| Enterprise Value | -17.95M |
Share Statistics
HOOKIPA Pharma Inc. currently has 12.20M shares outstanding.
| Shares Outstanding | 12.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 1.06, and the price-to-book ratio stands at -0.04.
| PE Ratio | N/A |
| PS Ratio | 1.06 |
| PB Ratio | -0.04 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | -0.35 |
| P/OCF Ratio | -0.35 |
Financial Position
HOOKIPA Pharma Inc. maintains a current ratio of 3.93, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.93 |
| Quick Ratio | 3.32 |
| Debt / Equity | 1.90 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -63.01 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -106,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
HOOKIPA Pharma Inc.'s stock has gained approximately 10.57692% over the past 52 weeks. The 50-day moving average sits at 1.15, while the 200-day moving average is 1.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 10.57692% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 1.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, HOOKIPA Pharma Inc. generated 14.86M in revenue and converted that into -56.00M in net income, yielding earnings per share of -4.45. EBITDA reached -53.88M, while operating income came in at -56.13M.
| Revenue | 14.86M |
| Gross Profit | N/A |
| Operating Income | -56.13M |
| Pretax Income | -56.11M |
| Net Income | -56.00M |
| EBITDA | -53.88M |
| EBIT | -56.13M |
| Earnings Per Share (EPS) | -4.45 |
Balance Sheet
HOOKIPA Pharma Inc. holds 34.23M in cash and equivalents against 546,000.00 in total debt, resulting in a net debt position of -34.23M. Total book value stands at -429.98M, with working capital of 38.52M providing operational flexibility.
| Cash & Cash Equivalents | 34.23M |
| Total Debt | 546,000.00 |
| Net Debt | -34.23M |
| Equity (Book Value) | -429.98M |
| Book Value Per Share | -34.16 |
| Working Capital | 38.52M |
Cash Flow
HOOKIPA Pharma Inc. produced -45.53M in operating cash flow over the past twelve months. After subtracting -53,000.00 in capital expenditures, free cash flow totaled -45.58M - equivalent to -3.62 per share.
| Operating Cash Flow | -45.53M |
| Capital Expenditures | -53,000.00 |
| Free Cash Flow | -45.58M |
| FCF Per Share | -3.62 |
Margins
HOOKIPA Pharma Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -377.82 and net profit margin of -376.98 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -377.82 |
| Pretax Margin | -377.69 |
| Profit Margin | -376.98 |
| EBITDA Margin | -362.66 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.82 |
| FCF Yield | -289.00 |
Stock Splits
HOOKIPA Pharma Inc.'s most recent stock split took place on July 10, 2024 with a 10:1 split ratio.
| Last Split Date | 7/10/2024 |
| Split Ratio | 10:1 |
Scores
HOOKIPA Pharma Inc. posts an Altman Z-Score of -13.38, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -13.38 |